Submit a comment
Samuel E. Gandy, … , Maria G. Buse, Rosalie K. Crouch
Citation Information: J Clin Invest. 1982;70(3):650-658. https://doi.org/10.1172/JCI110659.
Samuel E. Gandy, … , Maria G. Buse, Rosalie K. Crouch
Published September 1, 1982
Citation Information: J Clin Invest. 1982;70(3):650-658. https://doi.org/10.1172/JCI110659.
Abstract
Copper-zinc superoxide dismutase (SOD) is present in relatively high concentrations in the β-cells of human islets. The activity of the extracted enzyme is partially inhibited upon incubation with the diabetogenic drugs alloxan, streptozotocin, or Vacor. The role of this enzyme in protecting β-cells against chemically induced diabetes was further investigated.
Authors
Samuel E. Gandy, Maria G. Buse, Rosalie K. Crouch
Guidelines
The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.
- Comments appear on the Journal’s website and are linked from the original article’s web page.
- Authors are notified by email if their comments are posted.
- The Journal reserves the right to edit comments for length and clarity.
- No appeals will be considered.
- Comments are not indexed in PubMed.
Specific requirements
- Maximum length, 400 words
- Entered as plain text or HTML
- Author’s name and email address, to be posted with the comment
- Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
- Comments may not include figures
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)